Credits Available: 4.25 AMA PRA Category 1 Credit™/ MOC Points

Description: This dynamic course focuses on the exchange of best practices regarding the use of bispecifics in patients with R/R DLBCL including patient eligibility. Through this interactive, small-group activity, participants will review brief modules and patient cases to identify signs and symptoms of toxicities experienced while receiving treatment with bispecific antibodies for R/R DLBCL and also integrate protocols to manage CRS and ICANS effectively when managing patients. The group will gather for a live discussion via Zoom to share and exchange ideas on this topic.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Rabeya Molla

Memorial Sloan Kettering Caner Center
Lymphoma Clinical Pharmacy Specialist

I currently serve as a Clinical Pharmacy Specialist for the Lymphoma team at Memorial Sloan Kettering Cancer Center (MSKCC). I received my PharmD from LIU Brooklyn in 2020 and completed PGY1 Pharmacy Practice Residency at the Mount Sinai Hospital followed by a PGY2 Oncology Pharmacy Specialty Residency at Roswell Park Comprehensive Cancer Center. I have been managing patients with B and T cell lymphomas, CLL/SLL, WM, and a number of HLH patient in both the inpatient and outpatient setting for about 2-3 years.